Drug profile · INN
pegvaliase-pqpz
PALYNZIQ
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pegvaliase-pqpz (PALYNZIQ) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN pegvaliase-pqpz
Brand PALYNZIQ
Route INJECTION
Formulation INJECTABLE
Originator BioMarin International Limited
Frequently asked questions
What is pegvaliase-pqpz?
pegvaliase-pqpz (PALYNZIQ) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pegvaliase-pqpz?
PALYNZIQ is a marketed brand name for pegvaliase-pqpz. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegvaliase-pqpz?
pegvaliase-pqpz has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.